During the last session, Cemex S.A.B. De C.V. ADR (NYSE:CX)’s traded shares were 7.73 million, with the beta value of the company hitting 1.48. At the end of the trading day, the stock’s price was $8.83, reflecting an intraday loss of -3.50% or -$0.32. The 52-week high for the CX share is $9.27, that puts it down -4.98 from that peak though still a striking 41.34% gain since the share price plummeted to a 52-week low of $5.18. The company’s market capitalization is $13.35B, and the average intraday trading volume over the past 10 days was 11.15 million shares, and the average trade volume was 6.87 million shares over the past three months.
Cemex S.A.B. De C.V. ADR (NYSE:CX) trade information
Cemex S.A.B. De C.V. ADR (CX) registered a -3.50% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.50% in intraday trading to $8.83, hitting a weekly high. The stock’s 5-day price performance is -0.23%, and it has moved by 14.82% in 30 days. Based on these gigs, the overall price performance for the year is 63.22%. The short interest in Cemex S.A.B. De C.V. ADR (NYSE:CX) is 6.36 million shares and it means that shorts have 1.07 day(s) to cover.
Cemex S.A.B. De C.V. ADR (CX) estimates and forecasts
Statistics show that Cemex S.A.B. De C.V. ADR has outperformed its competitors in share price, compared to the industry in which it operates. Cemex S.A.B. De C.V. ADR (CX) shares have gone up 43.81% during the last six months, with a year-to-date growth rate more than the industry average at 683.33% against 4.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -13.30% this quarter and then jump 11.10% in the quarter after that. In the rating firms’ projections, revenue will increase 3.10% compared to the previous financial year.
Revenue for the current quarter is expected to be $4.11 billion as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to $4.7 billion by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $3.92 billion and $4.37 billion respectively. In this case, analysts expect current quarter sales to grow by 4.80% and then jump by 7.60% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -17.84%. While earnings are projected to return 2480.75% in 2024, the next five years will return 13.60% per annum.
CX Dividends
Cemex S.A.B. De C.V. ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cemex S.A.B. De C.V. ADR (NYSE:CX)’s Major holders
Cemex S.A.B. De C.V. ADR insiders own 0.00% of total outstanding shares while institutional holders control 30.49%, with the float percentage being 30.49%. Baillie Gifford and Company is the largest shareholder of the company, while 397 institutions own stock in it. As of Jun 29, 2023, the company held over 73.17 million shares (or 4.83% of all shares), a total value of $518.02 million in shares.
The next largest institutional holding, with 52.14 million shares, is of FMR, LLC’s that is approximately 3.44% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $369.12 million.
Also, the Mutual Funds coming in first place with the largest holdings of Cemex S.A.B. De C.V. ADR (CX) shares are Fidelity Series Emerging Markets Opportunities Fund and Europacific Growth Fund. Data provided on Aug 30, 2023 indicates that Fidelity Series Emerging Markets Opportunities Fund owns about 20.3 million shares. This amounts to just over 1.34 percent of the company’s overall shares, with a $161.81 million market value. The same data shows that the other fund manager holds slightly less at 18.78 million, or about 1.24% of the stock, which is worth about $132.94 million.
